Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

Accusing him of covering up the businessman’s “corruption”, Congress MP and Leader of Opposition in Lok Sabha Rahul Gandhi attacked Prime Minister Narendra Modi over his reply to a question related to ...

Join FOX 26's Caroline Collins and Rashi Vats as they take Caroline & Rashi on the road to H-E-B to help you get ready for Super Bowl Sunday! Caroline and Rashi dedicate this episode to the ...

Rahul Gandhi's approval as Leader of Opposition saw a decline with 27% voters rating him 'poor', while the Congress leader still remained the favourite to head the grand old party, according to the ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 1,981.81 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

No other corporate actions details are available.

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.